<DOC>
	<DOCNO>NCT01163422</DOCNO>
	<brief_summary>The purpose study determine whether cardiac resynchronization therapy use implant electronic pacemaker reduces morbidity associate chronic thromboembolic pulmonary hypertension</brief_summary>
	<brief_title>Right Ventricular Resynchronization Therapy</brief_title>
	<detailed_description>Rationale : The clinical severity right ventricular disease largely determine right-to-left ventricular dyssynchrony , i.e. , delay electrical activity right leave ventricle . Moreover , patient chronic thromboembolic pulmonary hypertension ( CTEPH ) , find acute correction dyssynchrony temporary pacing ( prior pulmonary endarterectomy , presently therapy choice CTEPH ) result significant improvement cardiac output . In study , aim establish whether chronic pacing use implant pacemaker confers long-lasting improvement cardiac output functional class . Objective : To study whether chronic pacing implanted pacemaker confers long-lasting improvement cardiac output functional class severely symptomatic CTEPH patient eligible pulmonary endarterectomy , pulmonary endarterectomy fail . Study design : Chronic intervention study , double-blinded , randomize , cross-over . Study population : Adult CTEPH patient eligible pulmonary endarterectomy , pulmonary endarterectomy fail . Intervention ( applicable ) : chronic right ventricular resynchronization therapy ( RVRT ) , i.e. , chronic right atrial , right ventricular , leave ventricular pacing use implant pacemaker . Main study parameters/endpoints : ( Duration ) improvement ( l/min ) cardiac output measure use Doppler echocardiography , functional class measure use 6-minute walking distance ( 6-MWD ) , right leave ventricular dimension ejection fraction ( 99mTechnetium scintigraphy ) , biomarkers heart failure ( serum NT-proBNP level ) , quality life ( SF-36 ) questionnaire . Design : Randomized , double-blind , cross-over study 2 arm 10 patient ( arm 1 2 ) . In arm 1 , RVRT switch immediately pacemaker implant , switch week 5 , switch start week 6 study end ( 32 week ) . In arm 2 , RVRT switch start week 5 pacemaker implant study end ( 32 week ) . At various follow-up visit week 1 , 4 , 5 , 6 , 8 , 12 , 16 , main study parameters/endpoints ( see previous paragraph ) assess .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Adult patient chronic thromboembolic pulmonary hypertension ( CTEPH ) ineligible pulmonary endarterectomy , pulmonary endarterectomy fail</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Right ventricular failure</keyword>
	<keyword>Pacemaker</keyword>
	<keyword>Cardiac resynchronization therapy</keyword>
	<keyword>Pulmonary hypertension</keyword>
</DOC>